drugset / Trial / NCT06250413

Autoflor -Lyophilized Capsulated Autological FMT to Restore Gut Microbiome After Treatment With Antibiotics

NCT06250413

Not yet recruiting 40 enrolled Otto Helve University of Helsinki · collab
RandomizedCrossoverQuadruple-blindSupportive care

Summary

In this clinical trial, our aim is to assess the effect of auto-FMT (Fecal microbiome transplantation) on the intestinal microbiota, after a course of antibiotics. 30 healthy adults are recruited. All are given a five day course of amoxicillin-clavulanate. The subjects are double blinded and randomized to two groups. Group A is given autologous FMT (auto-FMT) on day 7 (two days after the end of the course of antibiotics) and Group B is given auto-FMT on day 28 (23 days after the end of the course of antibiotics).

Timeline

Start
2024-02
Primary completion
2026-12
Completion
2027-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Amoxicillin Other / unclassified 875 mg
Background Clavulanate Unknown 125 mg

Indications